Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea

NCT01447251 is registered in ClinicalTrials.gov with Mike O'Callaghan Military Hospital as lead sponsor.

NCT NCT01447251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01447251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea
Lead sponsor
Mike O'Callaghan Military Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
July 31, 2014
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, obstructive sleep apnea